Richard P. Sloan, Ph.D.

Principal Investigator

Dr. Sloan’s principal work focuses on identifying the autonomic nervous system mechanisms linking psychological risk factors such as depression, hostility, and anxiety to heart disease. Funded research studies address various aspects of this problem.

Paula McKinley, Ph.D.

Co-Investigator

Dr. Paula McKinley examines the impact of adjuvant chemotherapy on cognitive function in women with breast cancer.

Yaakov Stern, Ph.D.

Co-Investigator

Along with Dr. Richard Sloan, Dr. Yaakov Stern is exploring potential non-pharmacologic interventions that might improve cognition or cognitive/functional outcomes in normal aging. These include aerobic exercise and experimental videogames.

Dr. Peter Shapiro, M.D.

Co-Investigator

Dr. Peter Shapiro’s research has focused on psychiatric outcome after organ transplantation and on psychological factors and psychiatric problems in heart disease. He was a co-investigator for the REMATCH and SADHART trials.

Scott Small, M.D.

Co-Investigator

Scott Small, MD is using a new functional magnetic resonance imaging (fMRI) analysis to identify which sub-regions of the hippocampus correlate with memory decline.

Kathleen McIntyre, LMSW

Co-Investigator

Kathleen McIntyre, LMSW is a social worker specializing in individual and group mental health treatments for health and mental health issues in adult outpatient populations.  Her research interests include evaluation of cognitive, behavioral, dialectical and mindfulness-based clinical interventions and exploration of how daily experiences of affect and interpersonal interaction impact physiological and psychological outcomes.